Bikman cites the STEP 1 extension, where he says people who quit semaglutide regained about two-thirds of lost weight within a year, with metabolic gains fading too.
Recap by typeshit. Post by Benjamin Bikman on X.
Early uptake of the Wegovy pill outpaced injectable incretin weight loss drugs at a similar stage, HealthDay reported on Oct. 22.
Leftover food can't tell researchers whether someone stopped eating from fullness or from feeling sick, and Medical Xpress explains why that gap matters.
Moss says he once believed GLP-1s caused far more muscle loss than ordinary calorie cutting. He now says he got that wrong.
Topol points to neoantigens, the proteins or peptides on cancer cell surfaces, as the base of personalized cancer therapies.
The BMC resident compared the two drugs on fracture risk in people with type 2 diabetes. He presented the work at the bone research meeting in Boston.
Retatrutide has no FDA approval and is still being tested, yet CBS News says it is being advertised widely. Worth a look for anyone seeing those promos.
Loading…